|
|
What: Luncheon with the Experts presented by the Carcinoid Cancer Foundation
Who: Sukhmani K. Padda, MD, is the featured guest
When: Thursday, September 2, 2021 from 12 noon to 1 pm, Eastern Time
Where: CCF’s Facebook Page, https://www.facebook.com/Carcinoid/. Just come to the page at noon and the program will begin. There is no need to register nor is there a special link.
For anyone not on Facebook, each of the presentations in the series is available on CCF’s YouTube channel, https://www.youtube.com/user/CarcinoidNETs. To receive notifications of all new videos on our YouTube channel, CLICK LIKE, SUBSCRIBE and HIT THE BELL to receive notifications each time a new video is uploaded.
| |
Sukhmani K. Padda, MD, thoracic medical oncologist, was recently named Director of Thoracic Medical Oncology at Cedars-Sinai Cancer in Los Angeles, California. In collaboration with multidisciplinary clinical experts and scientists, Dr. Padda's work focuses on expanding clinical trials and translational research in thoracic oncology. The ultimate goal of this research is to improve the outcomes of patients with thoracic malignancies.
Dr. Padda has a particular interest in improving treatment for patients with rare thoracic tumors — such as thymic malignancies and lung neuroendocrine tumors — and genomic subsets of lung cancer, such as KRAS- and EGFR-positive tumors. Dr. Padda also conducts research into tumor biomarkers to help determine optimal treatments for patients.
She works with thoracic oncology experts around the country, leading and participating in clinical trials through the National Cancer Institute (NCI) Cancer Therapy Evaluation Program (CTEP) Cooperative Groups (e.g., ECOG, SWOG). She chairs the International Association for the Study of Lung Cancer (IASLC) Career Development/Fellowship Committee, which provides funding to early career lung cancer researchers around the world. Dr. Padda is a member of the North American Neuroendocrine Tumor Society (NANETS) and International Thymic Malignancy Interest Group (ITMIG). She has authored and co-authored dozens of papers and articles for peer-reviewed publications and is a peer reviewer for a number of prestigious cancer journals, including the Journal of Clinical Oncology and JAMA Oncology.
| |
|
|
|
|
|
|
|
